Optiray 300 solution for injection 20ml bottles Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

optiray 300 solution for injection 20ml bottles

guerbet laboratories ltd - ioversol - solution for injection - 300mg/1ml

Optiray 300 solution for infusion 50ml power injector pre-filled syringes Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

optiray 300 solution for infusion 50ml power injector pre-filled syringes

guerbet laboratories ltd - ioversol - solution for infusion - 300mg/1ml

Optiray 300 solution for infusion 75ml power injector pre-filled syringes Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

optiray 300 solution for infusion 75ml power injector pre-filled syringes

guerbet laboratories ltd - ioversol - solution for infusion - 300mg/1ml

Optiray 300 mg I/ml (31,8 g/50 ml) inj. sol. i.arter. vial Ubelgiji - Kiingereza - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

optiray 300 mg i/ml (31,8 g/50 ml) inj. sol. i.arter. vial

guerbet - ioversol 12,72 g/20 ml - solution for injection - 300 mg i/ml - ioversol 31800 mg - ioversol

Optiray 300 mg I/ml (318 g/500 ml) inj. sol. i.arter. vial Ubelgiji - Kiingereza - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

optiray 300 mg i/ml (318 g/500 ml) inj. sol. i.arter. vial

guerbet - ioversol 12,72 g/20 ml - solution for injection - 300 mg i/ml - ioversol 636 mg/ml - ioversol

Optiray 300 mg I/ml (12,72 g/20 ml) inj. sol. i.arter. vial Ubelgiji - Kiingereza - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

optiray 300 mg i/ml (12,72 g/20 ml) inj. sol. i.arter. vial

guerbet - ioversol 12,72 g/20 ml - solution for injection - 300 mg i/ml - ioversol 12720 mg - ioversol

Optiray 300 mg I/ml (63,6 g/100 ml) inj. sol. i.arter. vial Ubelgiji - Kiingereza - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

optiray 300 mg i/ml (63,6 g/100 ml) inj. sol. i.arter. vial

guerbet - ioversol 12,72 g/20 ml - solution for injection - 300 mg i/ml - ioversol 63600 mg - ioversol

Optiray 300 mg I/ml (127,2 g/200 ml) inj. sol. i.arter. vial Ubelgiji - Kiingereza - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

optiray 300 mg i/ml (127,2 g/200 ml) inj. sol. i.arter. vial

guerbet - ioversol 12,72 g/20 ml - solution for injection - 300 mg i/ml - ioversol 127200 mg - ioversol

Optiray 300 mg I/ml (38,16 g/60 ml) inj. sol. i.arter. vial Ubelgiji - Kiingereza - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

optiray 300 mg i/ml (38,16 g/60 ml) inj. sol. i.arter. vial

guerbet - ioversol 12,72 g/20 ml - solution for injection - 300 mg i/ml - ioversol 38160 mg - ioversol

OPTIRAY 350- ioversol injection OPTIRAY 320- ioversol injection OPTIRAY 300- ioversol injection Marekani - Kiingereza - NLM (National Library of Medicine)

optiray 350- ioversol injection optiray 320- ioversol injection optiray 300- ioversol injection

liebel-flarsheim company llc - ioversol (unii: n3rib7x24k) (ioversol - unii:n3rib7x24k) - optiray is indicated for: in adults - optiray 300: cerebral arteriography, and peripheral arteriography. - optiray 320: cerebral arteriography, peripheral arteriography, visceral and renal arteriography, aortography, coronary arteriography, and left ventriculography. - optiray 350: peripheral arteriography, coronary arteriography, and left ventriculography. in pediatric patients - optiray 320 and optiray 350: angiocardiography. in adults - optiray 300: ct imaging of the head and body, venography, and intravenous excretory urography. - optiray 320: ct imaging of the head and body, venography, and intravenous excretory urography. - optiray 350: ct imaging of the head and body, venography, intravenous excretory urography, and intravenous digital subtraction angiography (iv-dsa). in pediatric patients - optiray 320: ct imaging of the head and body, and intravenous excretory urography. symptomatic hyperthyroidism. risk summary postmarketing data with optiray use in pregnant women are insufficient